AbCellera to Participate at Upcoming Investor Conferences in May and June
AbCellera (Nasdaq: ABCL) has announced its upcoming participation in two major investor conferences. The company will attend the Bloom Burton & Co. Healthcare Investor Conference scheduled for May 5-6, and the Goldman Sachs 46th Annual Global Healthcare conference taking place June 9-11. Interested parties can find more details on AbCellera's Investor Relations website.
AbCellera (Nasdaq: ABCL) ha annunciato la sua prossima partecipazione a due importanti conferenze per investitori. L'azienda parteciperà alla Bloom Burton & Co. Healthcare Investor Conference, programmata per il 5-6 maggio, e alla Goldman Sachs 46th Annual Global Healthcare Conference, che si svolgerà dal 9 all'11 giugno. Le parti interessate possono trovare ulteriori dettagli sul sito web delle Relazioni con gli Investitori di AbCellera.
AbCellera (Nasdaq: ABCL) ha anunciado su próxima participación en dos importantes conferencias para inversores. La compañía asistirá a la Bloom Burton & Co. Healthcare Investor Conference programada para el 5 y 6 de mayo, y a la Goldman Sachs 46th Annual Global Healthcare Conference, que tendrá lugar del 9 al 11 de junio. Las partes interesadas pueden encontrar más detalles en el sitio web de Relaciones con Inversores de AbCellera.
AbCellera (Nasdaq: ABCL)은 두 개의 주요 투자자 회의에 참여할 예정이라고 발표했습니다. 이 회사는 5월 5-6일에 예정된 Bloom Burton & Co. Healthcare Investor Conference와 6월 9-11일에 열리는 Goldman Sachs 제46회 연례 글로벌 헬스케어 회의에 참석할 것입니다. 관심 있는 분들은 AbCellera의 투자자 관계 웹사이트에서 더 많은 세부정보를 확인할 수 있습니다.
AbCellera (Nasdaq: ABCL) a annoncé sa prochaine participation à deux grandes conférences pour investisseurs. L'entreprise assistera à la Bloom Burton & Co. Healthcare Investor Conference prévue pour les 5 et 6 mai, et à la Goldman Sachs 46th Annual Global Healthcare Conference qui se tiendra du 9 au 11 juin. Les parties intéressées peuvent trouver plus de détails sur le site web des Relations Investisseurs d'AbCellera.
AbCellera (Nasdaq: ABCL) hat seine bevorstehende Teilnahme an zwei wichtigen Investorenkonferenzen bekannt gegeben. Das Unternehmen wird an der Bloom Burton & Co. Healthcare Investor Conference teilnehmen, die für den 5.-6. Mai geplant ist, sowie an der Goldman Sachs 46th Annual Global Healthcare Conference, die vom 9. bis 11. Juni stattfindet. Interessierte Parteien können weitere Details auf der Website der Investor Relations von AbCellera finden.
- None.
- None.
- Bloom Burton & Co. Healthcare Investor Conference, May 5-6
- Goldman Sachs 46th Annual Global Healthcare conference, June 9-11
Visit AbCellera's Investor Relations website for additional information.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s platform integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. For more information, please visit www.abcellera.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250408784694/en/
Inquiries
Media: Tiffany Chiu; media@abcellera.com, +1(236)521-6774
Business Development: Murray McCutcheon, Ph.D.; partnering@abcellera.com, +1(604)559-9005
Investor Relations: Peter Ahn; ir@abcellera.com, +1(778)729-9116
Source: AbCellera Biologics Inc.
FAQ
Which investor conferences will AbCellera (ABCL) attend in May and June 2023?
When is AbCellera (ABCL) presenting at the Goldman Sachs Healthcare conference?
Where can investors find more information about AbCellera's (ABCL) conference presentations?
What is the schedule for AbCellera's (ABCL) Bloom Burton conference participation?
